BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22933702)

  • 1. Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.
    Samy M; Gattolliat CH; Pendino F; Hillion J; Nguyen E; Bombard S; Douc-Rasy S; Bénard J; Ségal-Bendirdjian E
    Mol Cancer Ther; 2012 Nov; 11(11):2384-93. PubMed ID: 22933702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
    Peifer M; Hertwig F; Roels F; Dreidax D; Gartlgruber M; Menon R; Krämer A; Roncaioli JL; Sand F; Heuckmann JM; Ikram F; Schmidt R; Ackermann S; Engesser A; Kahlert Y; Vogel W; Altmüller J; Nürnberg P; Thierry-Mieg J; Thierry-Mieg D; Mariappan A; Heynck S; Mariotti E; Henrich KO; Gloeckner C; Bosco G; Leuschner I; Schweiger MR; Savelyeva L; Watkins SC; Shao C; Bell E; Höfer T; Achter V; Lang U; Theissen J; Volland R; Saadati M; Eggert A; de Wilde B; Berthold F; Peng Z; Zhao C; Shi L; Ortmann M; Büttner R; Perner S; Hero B; Schramm A; Schulte JH; Herrmann C; O'Sullivan RJ; Westermann F; Thomas RK; Fischer M
    Nature; 2015 Oct; 526(7575):700-4. PubMed ID: 26466568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2003 Mar; 162(3):1019-26. PubMed ID: 12598334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells.
    Rao Y; Xiong W; Liu H; Jia C; Zhang H; Cui Z; Zhang Y; Cui J
    Breast Cancer; 2016 Mar; 23(2):216-23. PubMed ID: 25098685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.
    Chakrabarti M; Banik NL; Ray SK
    Exp Cell Res; 2013 Jun; 319(10):1575-85. PubMed ID: 23562653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
    Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
    Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.
    Nakajima A; Tauchi T; Sashida G; Sumi M; Abe K; Yamamoto K; Ohyashiki JH; Ohyashiki K
    Leukemia; 2003 Mar; 17(3):560-7. PubMed ID: 12646945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
    Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P
    Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
    Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
    Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
    Akter J; Kamijo T
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
    Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
    Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes].
    Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
    Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor‑related apoptosis‑inducing ligand‑induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.
    Zhao X; Zhang C; Le Z; Zeng S; Pan C; Shi J; Wang J; Zhao X
    Int J Mol Med; 2018 Sep; 42(3):1283-1294. PubMed ID: 29901096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
    Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
    Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling.
    Duffy DJ; Krstic A; Schwarzl T; Higgins DG; Kolch W
    Mol Cancer Ther; 2014 Feb; 13(2):454-67. PubMed ID: 24282277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of dominant-negative telomerase function.
    Nguyen BN; Elmore LW; Holt SE
    Cell Cycle; 2009 Oct; 8(19):3227-33. PubMed ID: 19738429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells.
    Das A; Banik NL; Ray SK
    Int J Oncol; 2009 Mar; 34(3):757-65. PubMed ID: 19212680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.